306 related articles for article (PubMed ID: 19650915)
1. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.
Dellis O; Arbabian A; Brouland JP; Kovàcs T; Rowe M; Chomienne C; Joab I; Papp B
Mol Cancer; 2009 Aug; 8():59. PubMed ID: 19650915
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells.
Dellis O; Arbabian A; Papp B; Rowe M; Joab I; Chomienne C
J Biol Chem; 2011 May; 286(21):18583-92. PubMed ID: 21454636
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
4. Induction of endoplasmic reticulum calcium pump expression during early leukemic B cell differentiation.
Aït Ghezali L; Arbabian A; Roudot H; Brouland JP; Baran-Marszak F; Salvaris E; Boyd A; Drexler HG; Enyedi A; Letestu R; Varin-Blank N; Papp B
J Exp Clin Cancer Res; 2017 Jun; 36(1):87. PubMed ID: 28651627
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum calcium pumps and cancer.
Arbabian A; Brouland JP; Gélébart P; Kovàcs T; Bobe R; Enouf J; Papp B
Biofactors; 2011; 37(3):139-49. PubMed ID: 21674635
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic Reticulum Calcium Pumps and Tumor Cell Differentiation.
Papp B; Launay S; Gélébart P; Arbabian A; Enyedi A; Brouland JP; Carosella ED; Adle-Biassette H
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397400
[TBL] [Abstract][Full Text] [Related]
7. Modulation of endoplasmic reticulum calcium pump expression during lung cancer cell differentiation.
Arbabian A; Brouland JP; Apáti Á; Pászty K; Hegedűs L; Enyedi Á; Chomienne C; Papp B
FEBS J; 2013 Nov; 280(21):5408-18. PubMed ID: 23157274
[TBL] [Abstract][Full Text] [Related]
8. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
9. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
[TBL] [Abstract][Full Text] [Related]
10. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
[TBL] [Abstract][Full Text] [Related]
11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
12. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
13. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
14. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ
PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817
[TBL] [Abstract][Full Text] [Related]
15. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
[TBL] [Abstract][Full Text] [Related]
16. The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis.
Brouland JP; Gélébart P; Kovàcs T; Enouf J; Grossmann J; Papp B
Am J Pathol; 2005 Jul; 167(1):233-42. PubMed ID: 15972967
[TBL] [Abstract][Full Text] [Related]
17. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
19. IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.
Kis LL; Salamon D; Persson EK; Nagy N; Scheeren FA; Spits H; Klein G; Klein E
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):872-7. PubMed ID: 20080768
[TBL] [Abstract][Full Text] [Related]
20. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
